Savona, Italy

Valtero Canepa

This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Dibra S.p.a.. Active years: 1998.


% Patents Active = 100.0


Average Co-Inventor Count = 2.0

ph-index = 1

Forward Citations = 5(Granted Patents)


Company Filing History:


Years Active: 1998

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Valtero Canepa: Innovator in Diagnostic Contrast Compositions

Introduction

Valtero Canepa is a notable inventor based in Savona, Italy. He has made significant contributions to the field of diagnostic imaging through his innovative work. His expertise is particularly evident in his patent for a container designed for diagnostic contrast compositions.

Latest Patents

Valtero Canepa holds a patent for a container specifically intended for diagnostic contrast compositions. This invention aims to improve the storage and delivery of contrast agents used in medical imaging procedures. His patent portfolio includes 1 patent that showcases his commitment to advancing healthcare technology.

Career Highlights

Throughout his career, Valtero Canepa has worked with prominent companies in the medical imaging sector. He has been associated with Dibra S.p.a. and Bracco Imaging S.p.a., where he contributed to various projects that enhance diagnostic capabilities. His work has had a lasting impact on the industry, particularly in the development of innovative solutions for medical imaging.

Collaborations

Valtero has collaborated with several professionals in his field, including Christoph De Haen. These partnerships have allowed him to leverage diverse expertise and drive forward-thinking innovations in diagnostic imaging.

Conclusion

Valtero Canepa's contributions to the field of diagnostic contrast compositions highlight his role as an influential inventor. His work continues to inspire advancements in medical technology, ultimately benefiting patient care and diagnostic accuracy.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…